Michael Kostukovsky
Lawyers
Filters
Avid Bioservices $160 million convertible senior notes offering
The convertible notes are due 2029
NGM Biopharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Lucid $3 billion public offering of stock and concurrent private placement
We advised Lucid on the transactions
Lucid $600 million at-the-market offering and $915 million additional investment
The common stock is listed on Nasdaq
TaskUs upsized $766.9 million follow-on offering
We advised the underwriters on the secondary offering
ForgeRock $316 million IPO
We advised the underwriters on the IPO and NYSE listing
Lucid Motors $24 billion combination with Churchill Capital Corp IV
We are advising Lucid Motors on its combination with a SPAC